We have previously shown that v-erb A expression strongly stimulates quail myoblast proliferation and dierentiation without alteration of the triiodothyronine (T3) in¯uence in this cell type. In order to understand the molecular basis of v-erb A action in myoblasts, we have studied the in¯uence of this oncoprotein on c-erb Aa1 encoded T3 nuclear receptor (TRa) activity. In transfection experiments, v-erb A did not inhibit the T3-dependent c-erb Aa1 transcriptional activity in QM7 myoblasts in contrast to its action in HeLa cells. However, it repressed the retinoic acid receptor RARa activity in both cell-types, indicating that v-erb A interactions with T3 or RA mediated transcription signi®cantly diers. In EMSA experiments using a TRE pa1 probe, T3Ra binds as three complexes in HeLa cells. We have previously identi®ed the slow migrating complex, undetectable in QM7 myoblasts, as a T3R/ RXR heterodimer. Interestingly, v-erb A inhibited binding of this complex in HeLa cells, but did not aect binding of the two other complexes in QM7 myoblasts. Expression of RXR (g isoform), the TRa dimerization partner absent in proliferating QM7 cells, restored inhibition of c-erb Aa1 transcriptional activity in these cells and abrogated the v-erb A myogenic in¯uence. Lastly, v-erb A induced a T3-independent cerb Aa1 activity in QM7 cells when cotransfected in equimolar ratio with the receptor, by inhibiting AP-1 activity and stimulating transcription of a reporter gene driven by a TRE sequence.
Introduction
The v-erb A oncogene has been discovered as one of the two oncogenes carried by the avian erythrobastosis virus (AEV) genome. It represents a mutated version of the c-erb Aa protooncogene encoding triiodothyronine (T3) nuclear receptor (Sap et al., 1986; Weinberger et al., 1986 ) a member of the steroid nuclear receptor together with glucocorticoid, androgen, oestrogen, vitamin D3, or retinoid receptors. The v-erb A oncoprotein diers from its cellular counterpart by fusion with gag-residues, N-terminal truncation, Cterminal deletion and several point mutations. It is no longer able to bind T3 due to the 9 amino acid Cterminal deletion (MunÄ oz et al., 1988) encompassing the ligand 2 binding domain (Horowitz et al., 1989) . In spite of two point mutations in the DNA binding domain, v-erb A still recognizes the Thyroid Hormone Response Elements (TREs) and Retinoid Response Elements (RAREs) with reduced anity (Damm et al., 1989; Rascle et al., 1994) and with a reduced spectrum when compared to these receptors Subauste and Koenig, 1995) .
Functional interferences between T3 or retinoic acid (RA) nuclear receptors and v-erb A have been demonstrated. First, v-erb A inhibits the liganded RAR and c-erb A transcriptional activity (Damm et al., 1989; Sap et al., 1989; Disela et al., 1991; Sande et al., 1993; Rascle et al., 1994) . Dierent hypotheses have been proposed to account for the v-erb A antagonism. It could compete with the receptors for binding to response elements, resulting in transcriptional silencing from these elements (Sap et al., 1989; Damm et al., 1989; Sharif and Privalsky, 1991; Baniahmad et al., 1992) . Alternatively, it could trap the receptors themselves or their heterodimerization partners into non functional complexes. The occurrence of v-erb A/T3R or or v-erb A/RAR heterodimers is still controversial despite the observation by Yen et al. (1994) of v-erb A/c-erb A heterodimers on the chicken lysozyme promoter. and Hermann et al. (1993) have reported that v-erb A can heterodimerize with RXRg. Therefore, verb A could interfere with the T3 and RA pathway by trapping their major heterodimer partner (Hermann et al., 1993) . Rascle et al. (1994) have reported that RXR/c-erb A heterodimers compete with a putative repressor (NFX) for binding to the distal element of the promoter of a T3 and v-erb A target gene (carbonic anhydrase II, CAII) resulting in transcriptional activation in avian erythroblasts. In this model, v-erb A does not compete with NFX but rather prevents the RXR/c-erb A/NFX competition by titrating RXR, thus enabling NFX to repress CAII transcription.
Lastly, an additional mechanism has been demonstrated for v-erb A action. Although it fails to repress AP-1 activity on its own (Zhang et al., 1991; Desbois et al., 1991a; Saatcioglu et al., 1993) , the oncoprotein overcomes the inactivation of AP-1 activity induced by T3 and RA liganded receptors (Desbois et al., 1991a) . This functional interference with the AP-1 pathway probably involves protein-protein interactions between v-erb A and members of the jun/fos family, T3 or RA receptors, or additional proteins crucial for functional AP-1/nuclear receptors interactions. Up to date, no clear evidences for such interactions have been published.
Such mechanisms have been proposed to explain how v-erb A interferes with the proliferation and dierentiation pathways in ®broblasts and erythroblasts Desbois et al., 1991b; Schroeder et al., 1992) . Nevertheless, the possibility that v-erb A could directly activate transcription through a set of T3 or RA independent genes cannot be excluded.
We have previously shown that v-erb A stimulates quail myoblast dierentiation in a T3 independent, cellspeci®c manner . Interestingly, v-erb A did not appear to antagonize the T3 action in quail myoblasts. Moreover, we have recently shown that RXR is crucial for the induction of TRa activity in avian myoblasts (Cassar-Malek et al., 1996) : (i) stimulation of transcriptional activity; (ii) induction of functional c-erb A/AP-1 interaction. In order to elucidate the molecular basis of v-erb A action in myoblasts, we have compared the in¯uence of this oncoprotein on T3-regulated mechanisms in HeLa cells (expressing all RXR isoforms. Titcomb et al., 1994) and in proliferating QM7 myoblasts (not expressing RXR; Cassar-Malek et al., 1996) . In this study, we demonstrate that RXR expression is required for v-erb A/c-erb A antagonism. This is the ®rst evidence that absence of RXR could induce a cell-speci®c v-erb A activity. Furthermore, we report that equimolar transfection of v-erb A and c-erb Aa1 in QM7 cells confers a ligand-independent transcriptional activity to the T3 receptor.
Results
v-erb A is a potent inhibitor of RARa transcriptional activity in myoblasts but does not in¯uence c-erb Aa1 transcriptional activity
In order to understand the T3-independent action of verb A in myoblasts, we have studied the in¯uence of this oncoprotein upon c-erb Aa1 transcriptional activity through a TRE pa1 in these cells. As numerous data concerning v-erb A molecular mechanisms were obtained using HeLa cells, we performed experiments in this cell type used as a positive control. HeLa cells and QM7 myoblasts were cotransfected with TRE pa1 -Glo-CAT reporter gene, pRS c-erb Aa1 and/or pRS verb A expression vectors in order to study the in¯uence of v-erb A overexpression upon T3-induced mechanisms (Figure 1a,b) .
As expected in HeLa cells, the strong stimulation of CAT activity induced by c-erb Aa1 expression in presence of 10 78 M T3 (tenfold when compared to control, P50.005) was signi®cantly inhibited by vverb A co-expression (P50.005; Figure 1a ). The same antagonism was observed between v-erb A and RARa in these cells (data not shown). In addition, as previously observed , no repression of T3 stimulated TRE pa1 reporter was observed when c-erb Aa1 and v-erb A (1:3) were cotransfected in QM7 myoblasts (Figure 1b) . Similar results were obtained using the molecular ratio 1:10 (data not shown). Interestingly, cotransfection of RARa/v-erb A (molecular ratio 1:3) resulted in a 75% inhibition of the RA activated reporter activity (P50.005; Figure 2 ). These data indicate that, in QM7 myoblasts, v-erb A behaves as a strong RARa antagonist but does not aect c-erb Aa transcriptional V-erb A does not alter the pattern of c-erb A binding to a TRE sequence in quail myoblasts
To determine the possible implication of a T3R partner in v-erb A/c-erb Aa1 antagonism, we studied the in¯uence of v-erb A on T3 receptor binding to a palindromic TRE. Whole extracts of c-erb A and/or verb A expressing QM7 or HeLa cells were analysed by EMSA using a synthetic TRE pa1 probe. Two T3R binding complexes displaying a similar mobility in both cell types (II and III, Figure 3a and b) were detected, none of them corresponding to a RXR/ T3R complex (Cassar-Malek et al., 1996) . In addition, a third complex previously identi®ed as a T3R/RXR complex was only detected in HeLa cells (complex I, Figure 3a ; Cassar-Malek et al., 1996) . When v-erb A and c-erb Aa1 were cotransfected, we failed to detect verb A/c-erb A heterodimeric binding complexes ( Figure  3a and b). In addition, whereas binding of the T3 receptor to TRE pa1 was not aected in QM7 myoblasts (Figure 3b ), v-erb A co-expression strongly inhibited formation of the c-erb Aa1 heterodimeric complex in HeLa cells ( Figure 3a) . As shown in a previous work (Cassar-Malek et al., 1996) , expression of RXRg and cerb Aa1 in QM7 myoblasts restored formation of an additional complex in these cells displaying the same mobility than complex I in HeLa cells (Figure 4 ). In addition, this complex was not detected when v-erb A 
RXRg expression restores the inhibition of c-erb A transcriptional activity by v-erb A in QM7 cells
As we have previously shown that RXR is the missing partner of c-erb A in QM7 cells, we studied the in¯uence of RXRg expression on v-erb A/c-erb A interactions in these cells. Transient transfection experiments were performed using the TRE pa1 -Glo-CAT reporter construct ( Figure 5 ). Basal CAT activity was increased when cells were stimulated either with In agreement with a previous study (Cassar-Malek et al., 1996) , we observed that c-erb A did not display, by itself, any transcriptional activity through a DR4-TRE in myoblasts. Interestingly, transient RXRg expression restored a liganded-T3R activity (10 78 M T3) as well as the ability of v-erb A (c-erb A/c-erb A/RXR, 3:1:1 molar ratio) to signi®cantly repress T3R activity (766%, P50.01, Figure 6 ).
RXR expression abolishes the v-erb A myogenic in¯uence
As RXR appears to be required for oncogenic v-erb A activity (Hermann et al., 1993 ; our present data), we next studied the in¯uence of RXRg expression on v-erb A stimulated myoblast dierentiation. Control and QM7 cells stably expressing RXRg were infected with the avian replication competent retrovirus CASBA 54 enabling expression of v-erb A, as previously described . Myoblast dierentiation was studied by cytoimmuno¯uorescence experiments assessing myoblast fusion and connectin (a muscle speci®c protein) accumulation.
In agreement with our previous data, v-erb A stimulated QM7 myoblast dierentiation independently of T3 addition (Figure 7c Cotransfection of c-erb Aa1 and v-erb A (molar ratio 1:1) in myoblasts induces a transcriptional stimulation of a TRE pa1 -Glo-CAT reporter gene and inhibits AP-1 activity in a T3 independent manner During this study, we observed that equimolar transfection of pRS v-erb A together with pRS c-erb Aa1 induced particular transcriptional activities in QM7 cells. Whereas neither c-erb Aa1 nor v-erb A transactivated the TRE pa1 -Glo-CAT construct, cotrans- and/or 9-cis RA (10 76 M) was performed when indicated in the Figure. Three independent experiments were performed Figure 6 RXRg expression induces c-erb A transcriptional activity through a DR4-TRE in QM7 myoblasts and restores the functional c-erb A/v-erb A antagonism. QM7 cells were transfected with 1 mg DR4-tk-CAT gene reporter, 2 mg of c-erb Aa1, 2 mg of RXRg, and/or 6 mg of v-erb A expression vectors. Incubation with T3 (10 78 M) was performed when indicated in the Figure. Three independent experiments were performed fection of both expression vectors in equimolar ratio induced a sixfold activation of the reporter CAT activity in the absence of T3 (P50.005; Figure 8a) . A signi®cant potentiation of CAT activity was also recorded in the presence of hormone (P50.05; Figure  6b ), in contrast to results obtained with c-erb A/v-erb A coexpressed in 1:3 ratios. The S61G mutant of v-erb A (glycine instead of serine at position 61) with no myogenic activity , failed to induce a similar transcriptional activation, in absence or presence of T3 (Figure 8 a,b) . Thus in myoblasts, verb A induces a potent stimulation of c-erb Aa1 transcriptional activity from a TRE pa1 , independently of T3, when expressed in 1:1 molar ratio. Interestingly, RXRg expression abolished this T3 independent transcriptional activity (data not shown).
We also studied the in¯uence of pRS v-erb A and pRS c-erb Aa1 cotransfection on AP-1 activity. As previously observed, neither v-erb A nor c-erb Aa1 alone aected the TPA stimulated activity of the (AP-1) 5 -tk-CAT reporter gene, in absence or presence of T3 (Figure 9a ). When both expression plasmids were Specific activity of v-erb A in myoblasts I Cassar-Malek et al transfected in 1:3 molecular ratio, no signi®cant modi®cation of CAT activity was recorded in absence or presence of hormone (Figure 9a ). However, equimolar cotransfection of these plasmids induced a signi®cant inhibition of CAT activity both in absence and presence of T3 (Figure 9a ; P50.025). Similar results were observed when the AP-1 activity assessed using the 773col-CAT reporter construct was stimulated by c-jun overexpression (Figure 9b) . Interestingly, coexpression of S61G v-erb A with c-erb Aa1 did not induce any inhibition of CAT activity (Figure 9c) . Altogether, these data indicate that v-erb A transfection in equimolar ratio with T3Ra restores functional T3Ra/AP-1 interactions in QM7 myoblasts, even in absence of T3. In addition, it appears that serine at position 61 in v-erb A is needed to confer such an activity to the oncoprotein in QM7 cells.
Discussion

v-erb A is only a RAR antagonist in avian myoblasts
In this work, we con®rm our previous observation that the v-erb A oncoprotein displays a cell speci®c activity . In contrast to others (Sap et al., 1989; Damm et al., 1989) and our own data obtained in HeLa cells, we observe that verb A does not inhibit the c-erb Aa1 ligand-dependent tanscriptional activity in QM7 myoblasts. However, according to Sharif and Privalsky (1991) and to Sande et al. (1993) , we have shown that v-erb A is a potent RARa antagonist in quail myoblast. Therefore, our data provide evidences that v-erb A/c-erb Aa1 and verbA/RARa antagonisms do not involve strictly identical mechanisms. In addition, Sharif and Privalsky (1991) reported that the inhibition of cell dierentiation by v-erb A was associated to a repression of T3R and also RAR activity. Our data indicating that v-erb A expression stimulates myoblast RXRg expression restores v-erb A/c-erb A antagonism in avian myoblasts.
Privalsky and co-workers reported data actually suggesting that v-erb A inhibits T3R function by competing for TRE occupancy . Our present data suggest that inhibition of T3R transcriptional activity does not exclusively occur by such a mechanism. In this work, we have shown that the inability of verb A to antagonize the c-erb A pathway in quail myoblast was associated to the absence of a T3R heterodimerization partner. By EMSA, we observed the binding of T3Ra to a TRE pa1 as three mobility complexes in HeLa cells. In a previous work, using speci®c antibodies raised against c-erb Aa1 or RXR, we clearly identi®ed the lowest mobility complex (I) as a T3R/RXR heterodimer (Cassar-Malek et al., 1996) . However, although demonstrating c-erbAa1 presence in complexes II and III, we have not attempted to exactly identify their nature. When compared to complex I mobility, mobilities of complexes II and III are similar to that described by Au-Fliegner et al. (1993) for respectively T3R homodimer and monomer using recombinant proteins. However, migration of the T3R/RAR heterodimer does not signi®cantly dier from that of the T3R homodimer. Therefore, the possibility that complex II could include the T3R/RAR heterodimer cannot be ruled out. Interestingly, in contrast to HeLa cells (Leid et al., 1992; Titcomb et al., 1994) , complex I is not detected in quail myoblasts in relation with the lack of RXR isoforms expression previously reported (Cassar-Malek et al., 1996) .
The in¯uence of v-erb A upon T3R binding to TRE pa1 diers according to the complex considered. Whereas binding of complexes II and III was not aected by the oncoprotein in both cell types, heterodimeric binding of T3R/RXR was strongly inhibited in HeLa cells. Moreover, transient RXR expression in QM7 myoblasts restored formation of complex I, whose binding to TRE pa1 was abrogated by v-erb A expression.
Altogether, these data demonstrate that the oncoprotein titrates out RXR in HeLa and QM7 cells. As an additional complex was not detected in these experiments, it seems likely that the v-erb A/RXR heterodimer does not signi®cantly bind to TRE, in agreement with a previous work of Rascle et al. (1994) .
The involvement of this mechanism in the functional v-erb A/c-erb A antagonism is clearly suggested by the present experimental data. First, the oncoprotein represses T3R transcriptional activity in HeLa cells expressing RXR, but not in avian myoblasts which does not express RXR (Cassar-Malek et al., 1996) . Second, transient RXR expression in QM7 cells induces: (i) formation of a T3R/RXR heterodimer; (ii) inhibition of its binding to TRE by v-erb A; (iii) restoration of the c-erb A/v-erb A antagonism. Therefore, all these data suggest that the ability of the oncoprotein to behave as a T3R antagonist depends on RXR expression in dierent cell types.
Furthermore, as we observed that RXR expression abrogates the v-erb A myogenic in¯uence, we also suggest that this receptor could partly de®ne the oncoprotein action upon cell dierentiation.
In QM7 myoblasts, we recently reported data demonstrating the occurrence of RXR independent activities of the T3R (Cassar-Malek et al., 1996) . In addition, we have shown that the oncoprotein does not aect T3 in¯uences in these cells , thus suggesting that such a pathway is not a verb A target. In the present study, we provide evidences that restoration of a RXR-dependent transcriptional activity of T3R by RXR expression in place of the RXR independent pathway, also restores the functional v-erb A/c-erb A antagonism. These data clearly suggest that v-erb A could selectively act upon RXR dependent pathways. Such a possibility could satisfactorily explain the cell-speci®c activity of the oncoprotein demonstrated in our work present study) .
As RXR is necessary to induce a T3R transcriptional activity through a DR4-TRE, titration of this cerb A partner by v-erb A could satisfactorily explain the v-erb A/c-erb A antagonism observed when using this particular TRE. How v-erb A could inhibit T3R transcriptional activity through a TREpal by titrating out RXR remains unclear. We have shown that RXR does not improve the transcriptional eciency of T3R through a TRE pa1 (Cassar-Malek et al., 1996; present study) . Therefore, a decrease in the number of RXR/ T3R heterodimers induced by v-erb A could impair cerb A transcriptional activity if this event leads to a reduction in the total number of T3Rs bound to TREs sequences. However, the high variability of the signal intensities corresponding to complexes II and III observed in our EMSA experiments did not allow us to observe such changes. Alternatively, v-erb A/RXR, but not v-erb A, could compete with T3R for binding to a rate-limiting protein involved in transcriptional activity. Interestingly, Kamei et al. (1996) recently reported that CBP (CREB binding protein) displays some of these features. However v-erb A/RXR interactions with CBP remains to be established.
In addition, our data indicate that in contrast to the verb A/T3R antagonism, the v-erb A/RAR antagonism occurs in avian myoblast without RXR expression. We previously reported that in contrast to T3R, inhibition of AP-1 activity by RAR does not require RXR expression (Cassar-Malek et al., 1996) . This last observation suggests that, at least in myoblasts, RAR activity is less RXR-dependent, thus rising two possibilities: (i) RAR activity could involve, in absence of RXR, another partner expressed in myoblasts sensitive to v-erb A inhibition; (ii) RAR could display by itself a signi®cant activity; in this hypothesis, taking in account the lower anity of this receptor than that of c-erb A for a TRE pa1 (Graupner et al., 1989) , v-erb A could eciently compete with RAR for the TRE occupancy.
V-erb A induces a T3 independent c-erb A activity in avian myoblasts
We observed peculiar properties of the equimolar transfection of v-erb A and c-erb Aa1 in quail myoblasts. In absence of T3, v-erb A induces a c-erb Aa1 transcriptional activity. These data are consistent Specific activity of v-erb A in myoblasts I Cassar-Malek et al with the work of Sharif and Privalsky (1992) reporting that cotransfection of v-erb A and RARb expression vectors in 2:1 molar ratio signi®cantly enhanced a bRARE-tk-CAT reporter activity in absence of retinoic acid. Interestingly, have shown that v-erb A does not behave as a RARb antagonist on this RARE. Moreover, we observed that equimolar v-erb A/c-erb A transfection induces an inhibition of AP-1 activity, even in absence of T3. Our ®ndings indicate that, in quail myoblasts, v-erb A is able to stimulate the c-erb Aa1 pathways in a ligand-independent manner (inhibition of AP-1 activity; transcriptional activation).
This property of the oncoprotein is physiologically relevant. Such an activity probably constitutes a molecular mechanism accounting for the myogenic activity of v-erb A. This hypothesis is well supported by our experimental data: (i) we have shown that T3 stimulates quail myoblasts dierentiation (Marchal et al., 1993) , thus indicating that activation of T3 pathways stimulates myogenesis; (ii) after retroviral infections used to observe the myogenic in¯uence of the oncoprotein, v-erb A expression level was not obviously dierent from endogenous c-erb A expression level; thus, transient transfection experiments (molecular ratio 1:1) performed in the present study were representative of our work demonstrating the myogenic activity of v-erb A; (iii) the S61G v-erb A mutant, devoided of myogenic activity , did not stimulate the T3 pathways when cotransfected with c-erb Aa1; (iv) RXRg expression abolished activation of the T3 pathway by wild type verb A and suppressed the myogenic activity of the oncoprotein.
However, molecular basis of the v-erb A/c-erb Aa1 interaction still remain to be elucidated. We speculated the existence of a direct interference between these two proteins. Up to date, no v-erb A/c-erb Aa1 complexes have been identi®ed on classical TREs, while Yen et al. (1994) have reported the binding of a rat c-erb aa1/verb A heterodimer on the InvPal6 chicken lysozyme TRE. As RXR/T3R heterodimers could induce a potent transcriptional activation of reporter gene expression on some synthetic TREs independently of T3 presence (Force et al., 1994) , we postulated a similar activity of a v-erb A/c-erb A heterodimer in QM7 cells. Conformational change induced by this physical interaction could account for the activation of such heterodimers, as previously reported for chick cerb A/rat c-erb A heterodimer (Forman et al., 1988) . Unfortunately, we have been unable so far to detect verb A/T3R complexes using a TRE pa1 or a DR4 motif. However, such heterodimers are probably not easily detectable depending on the TRE type; in addition, a possible instability of these complexes in vitro could strongly impair their detection.
Alternatively, it was shown that v-erb A interacts with recently discovered co-repressors N-Cor or SMRT (Horlein et al., 1995; Chen and Evans, 1995) . It could compete with c-erb A in equimolar ratio for N-Cor or SMRT interaction, thus derepressing basal transcription rate. However, such a possibility implies that NCor or SMRT are in limiting amounts in the cell. Moreover, as T3 disrupts c-erb A/co-repressor interactions, it does not explain the increase in liganded-T3R transcriptional activity by v-erb A.
Another mechanism might be hypothesized to account for the v-erb A myogenic in¯uence. As two point mutations occurred in the DNA binding domain of v-erb A in comparison to c-erb A, the P box amino acid sequence mainly responsible for sequence recognition of speci®c responsive elements is aected (Sap et al., 1986; Forman and Samuels, 1990) . According to the proposal of Fuerstenberg et al. (1992) , the existence of v-erb A speci®c responsive genes should be postulated. They probably include a set of genes susceptible to be directly involved in the regulation of myogenic dierentiation.
This hypothesis is well supported by our recent data demonstrating that COUP-Tf, sharing the same P box than v-erb A, also clearly stimulates quail myoblast dierentiation (Cassar-Malek., 1994) . These results suggest that these two orphan receptors could in¯uence a common set of genes. Further identification of v-erb A/COUP-Tf putative target genes in avian myoblasts will probably help to better understand the stimulation of quail myoblast dierentiation by v-erb A.
Materials and methods
Cell cultures
Myoblasts of the QM7 cell line (Antin and Ordahl, 1991) were grown in Earle 199 Medium (M199) supplemented with 0.2% tryptose phosphate broth, penicillin (100 IU/ml) and with 10% T3-depleted fetal calf serum (FCS). HeLa cells were routinely grown in 10% containing DMEM. Serum was T3-depleted according to Samuels et al. (1979) . After hormonal depletion, T3 levels measured by RIA were always lower than the detection limit of the assay (80 pmol/l).
Plasmids and reporter genes
The (AP-1) 5 -tk-CAT plasmid carrying ®ve AP-1 sites upstream of the thymidine kinase promoter linked to the CAT gene and the DR4-tk-CAT plasmids were kindly provided by P Chambon (LGME U184, Strasbourg, France). The collagenase promoter-CAT construct 773col CAT has been described elsewhere (Angel et al., 1987) and was kindly provided by PK Vogt (The Scripps Research Institute, La Jolla, USA). The TRE pa1-Glo-CAT plasmid carrying a synthetic palindromic TRE sequence upstream of the rabbit bglobin core promoter linked to CAT gene was described by Rascle et al. (1994) .
The chicken c-erb Aa1, v-erb A and S61G v-erb A expression vectors placed under the control of the RSV-LTR have been previously described Damm et al., 1989; Bonde et al., 1991) . The pRS chicken c-jun and pRS chicken RXRg expression vectors were respectively obtained from Dr PK Vogt (The Scripps Research Institute, La Jolla, USA) and Dr P Brickell (University College and Middlesex School of Medicine, London).
Transient cell transfection and assays for transcriptional activation
Twenty four hours before transfection 0.3610 6 HeLa cells or QM7 cells per 100 mm dish were plated. Transfection of plasmid DNA into the cells was performed using a calcium phosphate precipitation procedure (Wigler et al., 1987) . Brie¯y, 1 mg of reporter gene was transfected together with pRS c-erb Aa1 (2 mg) and/or pRS v-erb A (2 or 6 mg) expression plasmids as indicated in the Figure legends . The amount of RSV-LTR was kept constant by complementing with the pRS polyA`empty' expression vector. When indicated, pRS cRXRg was also cotransfected. All transfections also included 1 mg of pCMV bgalactosidase as an internal control to normalize for transfection eciencies. After a 16 ± 20 h exposure to precipitates, the cells were refed for an additional 24 h with depleted serum containing media and incubated with 10 78 M T3, 10 77 M RA or 10 76 M 9-cis-RA when indicated. bgalactosidase activity (Nielsen et al., 1983) and CAT enzymatic activity (Neumann et al., 1987) were measured as previously described. For each assay the initial rate of the enzymatic reaction (v=d[P]/dt) was determined. Results are expressed in per cent of control values after bgalactosidase normalization.
Electrophoretic Mobility Shift Assay (EMSA)
Gel mobility shift assays were performed according to Graupner et al. (1989) , using whole transfected cell extracts. HeLa cells or QM7 myoblasts were seeded at 0.3610 6 cell/100 mm dish 24 h before transfection, and respectively transfected with 10 mg pRS polyA, pRS cerb Aa1 and/or pRS v-erb A by calcium phosphate coprecipitation. After 48 h, cells were scrapped and pooled from two dishes, pelleted by centrifugation, and resuspended in 100 ml of buer containing 10 mM TRIS. HCl (pH 7.8), 400 mM KCl, 20% glycerol and 2 mM dithiothreitol. Cell lysates were obtained after four freezethaw cycles and centrifugated at 10 000 g. Protein amounts were determined using the BioRad Protein Assay in supernatant. Cell extracts were stored at 7708C.
For EMSA, various combinations of 10 mg of whole cell extracts were incubated in a 10 ml reaction mixture containing 10 mM HEPES (pH 7.9), 80 mM KCl, 1 mM dithiothreitol, 2.5 mM MgCl 2 , 10% glycerol, 3 mg poly dIdC, 5 mg BSA and 10 000 c.p.m. T4 polynucleotide kinase labeled probe for 20 mn at room temperature. After incubation, samples were subjected to electrophoresis through a 4.5% polyacrylamide gel in 0.26TBE (17.8 mM TRIS, 17.8 mM Borate and 0.5 mM EDTA) for 3 h under 150 V at 4 8 C, and analysed by autoradiography. TREpal (GATCCTCAGGTCAT-GACCT-TGAAA) was used as probe.
Statistical analysis
Statistical analysis were performed using the t-test (Snedecor, 1961) .
